EUVIMEDEUVIMED entdecken
LeserbriefKommentar

Leveraging Transcriptomics Data to Refine Immunotherapy Response Prediction in NSCLC: STK11 Deficiency and Beyond

Gulanbar Amori, Emiko Sugawara, Kentaro Inamura

Journal of Thoracic Oncology · 2023

DOI: 10.1016/j.jtho.2023.08.021 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Journal of Thoracic Oncology, 2023. Verfasst von Gulanbar Amori und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pathology, The Cancer Institute, Japanese Foundation for Cancer, Tokyo, Japan; Department of Pathology, The Cancer Institute Hospital, Ja…. Hauptthemen laut MEDLINE: Lung Neoplasms, Carcinoma, Non-Small-Cell Lung. Die Arbeit nennt 4 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science, Ichiro Kanehara Foundation for the Promotion of Medical Sciences and Medical Care, Takeda Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsCarcinoma, Non-Small-Cell LungHumansTranscriptomeProtein Serine-Threonine KinasesImmunotherapyMutationAMP-Activated Protein Kinase Kinases

Substanzen

Protein Serine-Threonine KinasesSTK11 protein, humanAMP-Activated Protein Kinase Kinases

Autor:innen und Institutionen

  • Division of Pathology, The Cancer Institute, Japanese Foundation for Cancer, Tokyo, Japan; Department of Pathology, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Division of Pathology, The Cancer Institute, Japanese Foundation for Cancer, Tokyo, Japan; Department of Pathology, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan. Electronic addres…

Förderung

  • Japan Society for the Promotion of Science
  • Ichiro Kanehara Foundation for the Promotion of Medical Sciences and Medical Care
  • Takeda Science Foundation
  • Mochida Memorial Foundation for Medical and Pharmaceutical Research
  • Foundation for Promotion of Cancer Research
  • Yakult Bio-Science Foundation
  • Japan Lung Cancer Society

Zitieren

APA

Amori, G., Sugawara, E., & Inamura, K. (2023). Leveraging Transcriptomics Data to Refine Immunotherapy Response Prediction in NSCLC: STK11 Deficiency and Beyond. Journal of Thoracic Oncology. https://doi.org/10.1016/j.jtho.2023.08.021

Vancouver

Amori G, Sugawara E, Inamura K. Leveraging Transcriptomics Data to Refine Immunotherapy Response Prediction in NSCLC: STK11 Deficiency and Beyond. Journal of Thoracic Oncology. 2023. doi:10.1016/j.jtho.2023.08.021

BibTeX
@article{Amori2023,
  author = {Amori, Gulanbar and Sugawara, Emiko and Inamura, Kentaro},
  title = {Leveraging Transcriptomics Data to Refine Immunotherapy Response Prediction in NSCLC: STK11 Deficiency and Beyond},
  journal = {Journal of Thoracic Oncology},
  year = {2023},
  doi = {10.1016/j.jtho.2023.08.021}
}
Kostenlos starten →